We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Cryopreserved Versus Liquid-Stored Platelets in Surgical Bleeding: Insights from the CLIP-II Randomized Noninferiority Trial

MedXY Editorial Team•Dec 13, 2025•Clinical Updates
cardiac surgeryhemostasisplatelet transfusion

Highlights

  • The CLIP-II trial is the first large randomized noninferiority study comparing cryopreserved platelets with conventional liquid-stored platelets for surgical bleeding control.
  • Cryopreserved platelets, despite a significantly longer shelf-life, did not demonstrate noninferior hemostatic effectiveness compared to liquid-stored platelets at 24 hours post-ICU admission.
  • Transfusion of cryopreserved platelets was associated with increased perioperative blood loss and greater need for additional blood product transfusions.
  • Safety outcomes were comparable, but patients receiving cryopreserved platelets had longer durations of ventilation and hospital stays.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Impact of Decompensated Cirrhosis on Cardiac Surgery Outcomes: Clinical and Economic ImplicationsDecompensated cirrhosis markedly elevates mortality, complications, and costs following cardiac surgery. Optimized risk models and tailored management are essential for improved patient outcomes.Sep 9, 2026Outcomes following major cardiac procedures in socially vulnerable patients are not improved at high-volume centersSocial vulnerability significantly elevates mortality and complications after major cardiac surgery, and treatment at high-volume centers does not mitigate these disparities, highlighting the need for systemic interventions beyond hospitalAug 18, 2026α-Gal Sensitization as a Cause of Severe Allergic Reactions in Group O Recipients of Group B/AB Plasma and PlateletsSevere allergic transfusion reactions in group O recipients receiving group B or AB plasma or platelets are linked to IgE antibodies against the α-Gal epitope, highlighting a novel immunological mechanism and potential risk stratification aJun 25, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Postoperative Atrial Fibrillation After Cardiac Surgery: Common, Variably Treated, and Linked to Worse 1-Year Outcomes
The VISION Cardiac Surgery cohort found POAF in about one-third of patients, with wide variation in discharge treatment. POAF strongly predicted later atrial fibrillation and was associated with higher 1-year mortality.
Jun 19, 2026
Rethinking Magnesium Prophylaxis for Postoperative Atrial Fibrillation in Cardiac Surgery: A Synthesis of Clinical EvidenceRecent high-quality randomized clinical trials and meta-analyses suggest that routine magnesium sulfate infusion does not effectively prevent postoperative atrial fibrillation in cardiac surgery, especially when used alongside standard betaJun 3, 2026
Beyond the Count: How Product Factors and High Thresholds Shape Pediatric Platelet Transfusion OutcomesA multicenter cohort study of 8,874 pediatric patients reveals that most prophylactic platelet transfusions occur above recommended thresholds. Factors such as pathogen reduction, additive solutions, and donor age significantly lower posttrFeb 9, 2026